Z-0148-2020 Class II Terminated

Recalled by Siemens Healthcare Diagnostics, Inc. — Tarrytown, NY

FDA device recall Z-0148-2020 was initiated by Siemens Healthcare Diagnostics, Inc. on July 30, 2019 and is designated Class II. Reason for recall: Atellica CH 930 Analyzer - Erroneous Indices for Hemolysis and Lipemia in Software versions 1.19.2 and below The recall status is terminated (terminated June 10, 2022). Affected quantity: 1125 units.

Recall Details

Product Type
Devices
Report Date
October 23, 2019
Initiation Date
July 30, 2019
Termination Date
June 10, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1125 units

Product Description

Siemens Atellica CH 930 Analyzer. Siemens Material Number (SMN): 11067000 Product Usage: automated, clinical chemistry analyzer to perform in vitro diagnostic tests on clinical specimens

Reason for Recall

Atellica CH 930 Analyzer - Erroneous Indices for Hemolysis and Lipemia in Software versions 1.19.2 and below

Distribution Pattern

Worldwide Distribution - US Nationwide Foreign: Argentina Australia Austria Bangladesh Belgium Brazil Bulgaria Canada Chile Colombia Czech Republic Denmark Ecuador Egypt Finland France Germany Greece Hungary India Indonesia Iran Ireland Israel Italy Japan Kuwait Latvia Malaysia Mexico Netherlands Nigeria Norway P.R. China Pakistan Philippines Poland Portugal Qatar Republic Korea Romania Russian Fed. Saudi Arabia Singapore Slovakia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey U.A.E. United Kingdom Uruguay Vietnam

Code Information

Software version: V1.19.2 and below